Literature DB >> 30989903

[Research progress on pathogenesis of ischemic stroke and traditional Chinese medicine commonly used for treatment of ischemic stroke].

Jing-Bo Zhu1, Yong-Hua Wang1, Zhong-Dong Hu2, Jun Li2.   

Abstract

Stroke has become the second leading cause of death in the world, and the most common type is the ischemic stroke. Due to its rapid onset and complex conditions, ischemic stroke is a major neurological disorder that causes disability. Ischemic stroke mainly results from atherosclerosis, and the pathogenesis of ischemic stroke mainly includes energy metabolism disorders in the brain, the toxicity of excitatory amino acids, oxidative/nitrification stress, inflammatory response, apoptosis, and autophagy. With the characteristics of multi-component and multi-target, traditional Chinese medicine could be used to treat ischemic stroke at different stages. This article summarized the latest research progress on the pathogenesis of ischemic stroke and commonly used traditional Chinese medicine for treatment of ischemic stroke in order to provide references for the further research and clinical treatment of ischemic stroke.

Entities:  

Keywords:  ischemic stroke; pathogenesis; research progress; traditional Chinese medicine

Mesh:

Year:  2019        PMID: 30989903     DOI: 10.19540/j.cnki.cjcmm.20180921.002

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  8 in total

1.  Knockdown of RMST Impedes Neuronal Apoptosis and Oxidative Stress in OGD/R-Induced Ischemic Stroke Via Depending on the miR-377/SEMA3A Signal Network.

Authors:  Lei Zhao; Meng Zhang; Fang Yan; Yuxia Cong
Journal:  Neurochem Res       Date:  2021-01-06       Impact factor: 3.996

2.  Network pharmacology and in vitro experimental verification to explore the mechanism of Sanhua decoction in the treatment of ischaemic stroke.

Authors:  Wei Zhang; Li Zhang; Wen Jun Wang; Shanbo Ma; Mingming Wang; Minna Yao; Ruili Li; Wei Wei Li; Xian Zhao; Dongmei Hu; Yi Ding; Jingwen Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 3.  Inhibition of Oxidative Stress: An Important Molecular Mechanism of Chinese Herbal Medicine (Astragalus membranaceus, Carthamus tinctorius L., Radix Salvia Miltiorrhizae, etc.) in the Treatment of Ischemic Stroke by Regulating the Antioxidant System.

Authors:  Xixi Zhao; Yu He; Yangyang Zhang; Haofang Wan; Haitong Wan; Jiehong Yang
Journal:  Oxid Med Cell Longev       Date:  2022-05-23       Impact factor: 7.310

Review 4.  Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke.

Authors:  Ting Zhu; Lei Wang; Yicheng Feng; Guibo Sun; Xiaobo Sun
Journal:  Oxid Med Cell Longev       Date:  2021-03-13       Impact factor: 6.543

5.  To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology.

Authors:  Xingyu Chen; Yue Wang; Ying Ma; Ruonan Wang; Dexi Zhao
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

6.  Study on the Effect of Self-Made Lifei Dingchuan Decoction Combined with Western Medicine on Cough Variant Asthma.

Authors:  Jiachun Li; Ziliang Huang; Keying Li; Xiaoyun Jian; Binghui Liang
Journal:  Comput Math Methods Med       Date:  2022-09-12       Impact factor: 2.809

Review 7.  Research progress on the mechanism of action of hesperetin in cerebral ischemia: a narrative review.

Authors:  Qingchun Mu; Yufei Zhang; Qian Cheng; Hanning Huang; Chunming Huang; Longguang Tang
Journal:  Ann Transl Med       Date:  2022-07

8.  Metabonomics Study on Naotaifang Extract Alleviating Neuronal Apoptosis after Cerebral Ischemia-Reperfusion Injury.

Authors:  Dehong Xu; Qidi Ai; Xiaoqing Chen; Zhaoguo Wang; Hongda Wei; Luobing Zhou; Zhigang Mei; Jinwen Ge
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-14       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.